1. Home
  2. ZD vs AMPH Comparison

ZD vs AMPH Comparison

Compare ZD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ziff Davis Inc.

ZD

Ziff Davis Inc.

HOLD

Current Price

$35.41

Market Cap

1.3B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$27.12

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZD
AMPH
Founded
1995
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
ZD
AMPH
Price
$35.41
$27.12
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$37.00
$31.20
AVG Volume (30 Days)
780.9K
459.2K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
92.61
N/A
EPS
2.65
2.27
Revenue
$1,457,379,000.00
$723,305,000.00
Revenue This Year
$7.37
$1.35
Revenue Next Year
$2.99
$5.10
P/E Ratio
$13.37
$11.90
Revenue Growth
5.70
N/A
52 Week Low
$28.55
$20.39
52 Week High
$60.06
$45.39

Technical Indicators

Market Signals
Indicator
ZD
AMPH
Relative Strength Index (RSI) 61.65 55.45
Support Level $32.41 $26.23
Resistance Level $36.10 $27.82
Average True Range (ATR) 1.30 0.90
MACD 0.69 0.09
Stochastic Oscillator 91.00 74.69

Price Performance

Historical Comparison
ZD
AMPH

About ZD Ziff Davis Inc.

Ziff Davis Inc is a focused digital media and internet company whose portfolio includes brands in technology, entertainment, shopping, health, cybersecurity, and martech. It has two reportable segments: Digital Media and Cybersecurity and Martech. The company's brands include Mashable, Ookla, Offers.com, IGN, and VPN among others. The majority of revenue is generated from Digital Media.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: